Loewy Caroline M

CIK 00013674518 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001367451

Recent Transactions

50 trades

Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-13+800→ 800 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−16,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−15,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−49,245→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−14,010→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−32,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−27,705→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−67,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−7,500→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−25,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−30,000→ 0 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-19+2,000→ 2,000 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Class A Common Stock
2024-02-14+5,828→ 5,828 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2024-01-24+14,010→ 14,010 total
Award
eFFECTOR Therapeutics, Inc.
Stock Option (Right to Buy)
2023-09-09+40,000→ 40,000 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2023-05-19−3,750→ 0 total
Exercise/Conversion
PhaseBio Pharmaceuticals Inc
Common Stock
2023-05-19+3,750→ 3,750 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2023-01-25+25,000→ 25,000 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 total
Award
PhaseBio Pharmaceuticals Inc
Restricted Stock Units
2022-05-19+3,750→ 3,750 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−20,000→ 0 total
Disposition to Issuer
ZOGENIX, INC.
Stock Option (Right to Buy)
2022-03-07−22,000→ 0 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2022-01-25+67,000→ 67,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2022-01-18+50,000→ 50,000 total
Other
CERO THERAPEUTICS HOLDINGS, INC.$CERO
Class B Common Stock
2021-10-08+17,500→ 17,500 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2021-06-03+14,000→ 14,000 total
Award
ZOGENIX, INC.
Stock Option (Right to Buy)
2021-05-27+22,000→ 22,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2021-01-26+32,000→ 32,000 total
Other
eFFECTOR Therapeutics, Inc.
Class B Common Stock
2021-01-12−17,500→ 17,500 total
Award
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2021-01-04+50,000→ 50,000 total
Award
ZOGENIX, INC.
Stock Option (Right to Buy)
2020-09-21+20,000→ 20,000 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2020-06-03+16,000→ 16,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-15+49,245→ 49,245 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2020-03-11+50,000→ 50,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2020-03-11+50,000→ 50,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2020-01-31+65,000→ 65,000 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2019-05-09+9,167→ 9,167 total
Award
PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
2019-02-27+8,900→ 8,900 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2019-01-29+27,705→ 27,705 total
Award
Aptose Biosciences Inc.$APTOF
Stock Options (Right to Buy)
2019-01-02+40,000→ 40,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2018-01-24+16,000→ 16,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2017-09-22+7,500→ 7,500 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2017-06-28+15,000→ 15,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2017-01-19+30,000→ 30,000 total
Award
CORCEPT THERAPEUTICS INC$CORT
Stock option (right to buy)
2008-11-28$1.02/sh+800,000→ 800,000 total
Award
PONIARD PHARMACEUTICALS, INC.
Stock Option
2008-01-03$4.18/sh+60,000→ 60,000 total
Award
PONIARD PHARMACEUTICALS, INC.
Stock Option
2007-06-14+35,000→ 35,000 total
Award
PONIARD PHARMACEUTICALS, INC.
Stock Option
2007-06-14+128,533→ 128,533 total
Award
PONIARD PHARMACEUTICALS, INC.
Stock Option
2007-06-14+60,000→ 60,000 total
Award
PONIARD PHARMACEUTICALS, INC.
Stock Option
2006-06-23$1.00/sh+600,000→ 600,000 total

Companies

Recent Filings

Address

C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BLVD., SUITE 130

NEWARK, CA, 94560

View on SEC.gov